What Is Kaposi’s Sarcoma? What Causes Kaposi’s Sarcoma?
- Tuesday, December 8, 2009, 17:59
- Health News
- 3
Kaposi’s sarcoma (KS) is a type of cancer. It causes growths under the skin, although they can grow in the lining of the mouth, nose, throat and other organs. It is different from other cancers as it starts in several areas of the body at once. Most cancers start in one place and then spread. KS causes abrasions or tumors (growths). They most commonly appear on the skin as small, flat, colored lesions that can be brown, blue, red or deep purple…


Go to Source
People who read this also read
- ESMO Conference On Sarcoma And GIST: Spotlight On Rare Tumors In Hunt For New Cancer Treatments
New breakthrough treatments for the most common cancers could soon come from cutting-edge research into some of the world's rarest tumors. At the ESMO Conference on Sarcoma and GIST, to be held in Milan, Italy, on 9 and 10 March 2010, researchers and some of the world's leading experts will discuss ... - NICE Instructs NHS On New Drug For Advanced Soft Tissue Sarcoma
New guidance published today (24 February) by the National Institute for Health and Clinical Excellence (NICE) will give a specific group of cancer patients access to a new drug on the NHS which could help extend their lives. The guidance recommends trabectedin (Yondelis) for the treatment of certai... - Early Trial Shows Drug Can Curb Ewing’s Sarcoma Growth
An early study of the drug figitumumab has found that in some patients it can curb the growth of Ewing's sarcoma - a cancer which affects mainly teenage boys. The study was led by Dr Johann de Bono, from The Institute of Cancer Research and The Royal Marsden Hospital, and funded by Pfizer, who devel... - NICE Draft Guidance Recommends New Treatment Option For Advanced Soft Tissue Sarcoma
A new treatment which could extend the lives of a specific group of cancer patients will be available on the NHS. In the final draft of guidance published today (21 December 2009) by the National Institute for Health and Clinical Excellence (NICE), the drug, trabectedin is recommended as a trea... - Autologous Stem Cell Transplantation For Soft Tissue Sarcoma: Insufficient Research Into Therapy
Due to a lack of suitable studies, it is unclear whether patients with soft tissue sarcoma can benefit from autologous haematopoietic stem cell transplantation. With this type of therapy, some of the patient's own (autologous) stem cells are removed at a convenient time and generally re-implanted af...